#Samsung study

Samsung announced that a joint study with Chung-Ang University Gwangmyeong Hospital in Korea found that the Samsung Galaxy Watch6 can predict vasovagal syncope (VVS) or sudden fainting episodes using health data collected by the smartwatch. A joint clinical study with Chung-Ang University Gwangmyeong Hospital in Korea showed the Samsung Galaxy Watch6 can detect signs of VVS using data gathered by the smartwatch. The study involved 132 patients with suspected VVS symptoms. According to Samsung, the system was able to predict fainting episodes up to five minutes before they happened with 84.6% accuracy. “This study is an example of how wearable technology can help shift healthcare from being designed for ‘post-care’ to a model of ‘preventive care,’” Jongmin Choi, Head of Health R&D Group, Mobile eXperience (MX) Business, Samsung Electronics states. Samsung also said the research was published in the European Heart Journal – Digital Health. The brand calls it the first study to show that a commercial smartwatch can predict fainting episodes in advance. The much awaited Omnia i900 from Samsung (see specs here) was released in the Philippines yesterday. Read more in our articles including "Samsung study finds Galaxy Watch6 can detect early signs of fainting" and "Samsung i900 Omnia Philippine Price".